|
ELL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.504120E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.186400E-02 |
| Normal-vs-Stage2 |
7.296000E-03 |
| Normal-vs-Stage3 |
4.069600E-02 |
| Normal-vs-Stage4 |
6.149500E-02 |
| Stage1-vs-Stage2 |
6.336000E-02 |
| Stage1-vs-Stage3 |
5.988000E-01 |
| Stage1-vs-Stage4 |
6.314600E-01 |
| Stage2-vs-Stage3 |
2.185600E-01 |
| Stage2-vs-Stage4 |
3.006600E-01 |
| Stage3-vs-Stage4 |
9.506200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.561600E-02 |
| Normal-vs-AfricanAmerican |
9.571800E-02 |
| Normal-vs-Asian |
5.135800E-01 |
| Caucasian-vs-AfricanAmerican |
6.354000E-01 |
| Caucasian-vs-Asian |
2.317000E-01 |
| AfricanAmerican-vs-Asian |
2.085000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.834000E-02 |
| Normal-vs-Female |
1.148040E-02 |
| Male-vs-Female |
4.066800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.220100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.594400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.060100E-03 |
| Normal-vs-Age(81-100Yrs) |
9.855400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.899200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.052300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.320400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.450800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.145600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.396180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.997900E-03 |
| Classical-VS-Follicular |
8.33022539836747E-12 |
| Classical-VS-Other |
3.780200E-01 |
| Classical-VS-Normal |
3.581600E-01 |
| Tall-VS-Follicular |
1.520020E-02 |
| Tall-VS-Other |
7.536600E-01 |
| Tall-VS-Normal |
6.460100E-03 |
| Follicular-VS-Other |
1.754000E-01 |
| Follicular-VS-Normal |
1.73430000027786E-07 |
| Other-VS-Normal |
2.676600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.876400E-03 |
| Normal-vs-N1 |
3.237600E-02 |
| N0-vs-N1 |
7.919200E-01 |
|
|
